AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Mirabovak 25mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Devak Formulations

Salt Composition

Mirabegron (25mg)

Overview Mirabovak 25mg Tablet ER

Extended-release Mirabovak 25mg tablets alleviate overactive bladder symptoms such as urinary frequency, urgency, and incontinence. This medication relaxes bladder muscles, improving urine storage capacity. Always adhere to your physician's prescribed dosage and duration for Mirabovak 25mg ER tablets; it may be taken with or without food. Swallow the tablet whole; avoid crushing or chewing. Discontinuing treatment prematurely may exacerbate symptoms, so complete the prescribed course for optimal results. Common side effects include constipation, headache, hypertension, rhinitis, urinary tract infections, tachycardia, and arthralgia. Report any persistent or bothersome side effects to your doctor immediately. Before commencing treatment, disclose all other medications and pre-existing health conditions, including pregnancy or breastfeeding. Patients with hepatic or renal impairment require close monitoring and regular check-ups as directed by their doctor.

Uses of Mirabovak 25mg Tablet ER

Managing symptoms associated with overactive bladder

Major Benefits of Mirabovak 25mg Tablet ER:

Administer this medication precisely as prescribed by your physician, respecting both dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Mirabovak 25mg Extended-Release Tablets can be consumed with or without food, although consistent timing is recommended.

Common Side effects of Mirabovak 25mg Tablet ER:

  • Constipation
  • Headache
  • High blood pressure
  • Nasal inflammation
  • Urinary tract infection
  • Fast heart rate
  • Joint pain

How to use Mirabovak 25mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 25mg extended-release Mirabovak tablet whole; avoid chewing, crushing, or breaking it. While it can be taken with or without food, consistency is key – take it at the same time each day.

How Mirabovak 25mg Tablet ER works:

Extended-release Mirabovak 25mg tablets function as a beta-3 adrenergic agonist. Their mechanism involves stimulating bladder beta-3 receptors, resulting in detrusor muscle relaxation and a reduction in urinary urgency, frequency, and incontinence.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Use of Mirabovak 25mg Extended-Release Tablets with alcohol requires careful consideration. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Mirabovak 25mg tablets may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Mirabovak 25mg tablets are likely not safe for use while breastfeeding. Studies in humans indicate a potential for the medication to transfer to breast milk, posing a risk to the infant.

DrivingDrivingSAFE

Driving ability is typically unaffected by Mirabovak 25mg Extended-Release Tablets.

KidneyKidneyCAUTION

Extended-release Mirabovak 25mg tablets require careful administration for individuals with significant kidney impairment. Dosage modification of Mirabovak 25mg extended-release tablets may be necessary. Physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should use Mirabovak 25mg Extended-Release tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. Mirabovak 25mg Extended-Release tablets are contraindicated in individuals with severe hepatic dysfunction.

What if you forget to take Mirabovak 25mg Tablet ER :

Should you forget a Mirabovak 25mg Extended-Release Tablet, take it immediately. However, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Mirabovak 25mg Tablet ER

LabelValue
Chemical Type Anilide-based compound
Developing Habits No.
Treatment Category Urology
Action Class Beta-3 agonist for bladder control

FAQs on Mirabovak 25mg Tablet ER

Mirabovak 25mg Tablet ER's full effects may become apparent after 8 weeks or more of treatment. Dosage adjustments may be considered after 4–8 weeks, depending on individual response.
Continue taking your Mirabovak 25mg Extended-Release Tablet, even if your symptoms improve. This medication treats overactive bladder symptoms—urgency, frequent urination, and incontinence—but doesn't cure the condition. Discontinuing treatment could cause your symptoms to return.
Mirabovak 25mg ER tablets don't interfere with sleep. Consult your doctor about any sleep issues.
Mirabovak 25mg Tablet ER should not be given to children under 18 because its safety and efficacy haven't been established in this age group.
No, consistent daily use, as prescribed, is crucial. This medication manages your condition, not cures it. Intermittent use prevents your bladder from adapting, leading to ineffective treatment and symptom recurrence.
Kidney, ureter, bladder, or urethra infection is a rare side effect of Mirabovak 25mg Tablet ER. While uncommon, renal stones and bladder pain have been reported. Patients with impaired kidney function should use caution and report any kidney-related symptoms to their doctor.
Caution is advised when taking Mirabovak 25mg Tablet ER if you have high blood pressure. Regular blood pressure monitoring is recommended, as this medication may elevate blood pressure in some individuals. It's contraindicated in patients with severe, uncontrolled hypertension.
Seek immediate medical help, regardless of symptoms. A Mirabovak 25mg Tablet ER overdose can elevate heart rate and blood pressure, potentially causing severe headache, palpitations, chest pain, and fatigue.
Mirabovak 25mg Tablet ER
197
MRP 240
17% off